Attorneys representing the state of Louisiana and 340B providers urged a federal judge to dismiss AstraZeneca’s lawsuit against Louisiana’s contract [...] …
Critics of the 340B program, including a former congressman who voted to create the program, have written recent editorials urging [...] …
Please Login or Become a Paid Subscriber to View this Content
When I thought about launching 340B Report, the first person I reached out to was Tom Mirga. Tom and I [...] …
Please Login or Become a Paid Subscriber to View this Content
Veteran 340B observers were surprised to see that Sen. Bill Cassidy (R-La.) has expanded his 340B investigation into community health [...] …
Please Login or Become a Paid Subscriber to View this Content
Federal regulators have approved a first-time 340B provider audit by a drug manufacturer to examine processes to prevent duplicate discounts [...] …
Please Login or Become a Paid Subscriber to View this Content
Federal regulators recently deferred a decision on whether to add identifiers to 340B drugs purchased under Medicare Part D. The [...] …
Please Login or Become a Paid Subscriber to View this Content
Who will succeed retiring Rep. Anna Eshoo (D-Calif.) as top Democrat on the House Energy & Commerce (E&C) subcommittee that [...] …
Please Login or Become a Paid Subscriber to View this Content
Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
In the wake of a high-profile federal court ruling casting doubt on the definition of eligible “patient” in the 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
The federal 340B program remains on track to publish a final rule this month revising its administrative dispute resolution (ADR) [...] …